Concepedia

Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models

Yunfang Su, Ningning Liu, Zijuan Zhang, Zijuan Zhang, Hao Li, Jinlian Ma, Ye Yuan, Ming Shi, Jihong Liu, Zhenrong Zhao,

European Journal of Pharmacology · 2022 · 37 citations · 29 references

References

29

Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease

Sangjune Kim, Seung‐Hwan Kwon, Tae‐In Kam et al. · Neuron · 2019 · 1.4K citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease

Christopher B. Forsyth, Kathleen M. Shannon, Jeffrey H. Kordower et al. · PLoS ONE · 2011 · 980 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Dilan Athauda, Kate Maclagan, Simon S. Skene et al. · The Lancet · 2017 · 851 citations · Full text

Medicine, Neurology, Pharmacology +12

Colonic inflammation in Parkinson's disease

David Devos, Thibaud Lebouvier, Bernard Lardeux et al. · Neurobiology of Disease · 2012 · 641 citations · Full text

Life Sciences, Neurology, Neuroscience +12

Progression of intestinal permeability changes and alpha‐synuclein expression in a mouse model of Parkinson's disease

Leo P. Kelly, Paul M. Carvey, Ali Keshavarzian et al. · Movement Disorders · 2013 · 314 citations

Life Sciences, Neurology, Neuroscience +17